New Delhi, Nov. 14 -- The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has extended the validity of ceiling prices of orthopaedic knee implants used in knee replacement systems by two months, till January 15, 2027.

According to a notification issued by the Ministry of Chemicals and Fertilisers on November 13, the extension will remain in force beyond the earlier deadline of November 15, 2026, unless amended by a subsequent notification.

The NPPA said representations received from manufacturers and industry associations were under its consideration, prompting the extension of the existing notification.

The ceiling prices were initially notified on August 16, 2017, through a notification, and...